asa guidelines for glp 1 agonists The New Weight Management Meds GLP-1 and Anesthesia: Considerations and

Medications like Ozempic, Wegovy, Zepbound and Saxenda have blown up in popularity since the 2020 pandemic

In Their Own Words In recent years, GLP-1 receptor agonists like semaglutide (sold under brand names Ozempic and Wegovy) have become revolutionary treatments for obesity and type 2 diabetes, offering substantial weight loss, and myriad other benefits including improved renal and cardiovascular health

Natural amylin: the forgotten satiety hormone What amylin is: 37-amino acid peptide hormone Co-secreted with insulin from pancreatic beta cells Released in response to meals (nutrient intake) Discovered in 1987 (relatively recent) Named "amylin" for amyloid-like structure Amylin's natural functions: Where amylin acts: Area postrema (brainstem) - primary satiety effect Nucleus accumbens (brain) - reward/feeding behavior Stomach smooth muscle - direct gastric slowing Pancreas alpha cells - glucagon suppression Amylin vs insulin (complementary hormones): Both secreted together from beta cells Insulin: Handles glucose uptake Amylin: Controls meal size and gastric emptying Work synergistically to regulate feeding and metabolism Learn fundamentals at SeekPeptides - explore what are peptides , how peptides work , and peptides for weight loss

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Novo Nordisk, the maker of Wegovy, introduced its GLP-1 pill for weight loss in early January, while Eli Lilly's pill, Foundayo, began shipping in April